CAS RN: 1637752-37-4
4`-BROMOSPIRO[CYCLOPROPANE-1,3`-INDOLIN]-2`-ONE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20260322
250mg
Out of stock
15 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1637752-37-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1637752-37-4 / 4-bromospiro[1H-indole-3,1'-cyclopropane]-2-one
Standard CAS: 1637752-37-4
Multi CAS: No
Basic Information
copy
CAS
1637752-37-4 copy
Multi CAS
No copy
Molecular Formula
C10H8BrNO copy
Molecular Weight
238.080000 copy
Exact Mass
236.978930 copy
SMILES
C1CC12C3=C(C=CC=C3Br)NC2=O copy
InChI
InChI=1S/C10H8BrNO/c11-6-2-1-3-7-8(6)10(4-5-10)9(13)12-7/h1-3H,4-5H2,(H,12,13) copy
InChIKey
PSJOQBQRAHOTPT-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Aromatic heavy atom count
6 copy
Fraction Csp3
0.3 copy
H-bond acceptors
1 copy
H-bond donors
1 copy
Molar refractivity
53.68 copy
TPSA
29.1 copy
LogP / Solubility
WLOGP
2.43 copy
MLOGP
2.15 copy
XLogP3
1.8 copy
Consensus LogP
2.13 copy
Log S (ESOL)
-3.19 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-3.27 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.23 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.45 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy